Whitehawk Therapeutics, Inc. financial data

Symbol
WHWK on Nasdaq
Industry
Pharmaceutical Preparations
Location
2 Headquarters Plaza, East Building, 11 Th Floor, Morristown, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Aadi Bioscience, Inc. (to 3/18/2025), Aerpio Pharmaceuticals, Inc. (to 8/23/2021), ZETA ACQUISITION CORP II (to 3/13/2017)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 446 % -38.9%
Quick Ratio 30.5 % +36.7%
Debt-to-equity 26.9 % +44.5%
Return On Equity -87.7 % -66.9%
Return On Assets -69.1 % -56%
Operating Margin -260 % +12.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.8M shares +90.5%
Common Stock, Shares, Outstanding 24.7M shares +0.52%
Entity Public Float 24.4M USD -78%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27M shares +0.42%
Weighted Average Number of Shares Outstanding, Diluted 27M shares +0.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 26M USD +6.69%
Research and Development Expense 51M USD +4.29%
Costs and Expenses 93.4M USD -2.96%
Operating Income (Loss) -67.5M USD +6.22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3M USD -12.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -63.7M USD +3.15%
Earnings Per Share, Basic -2.36 USD/shares +3.28%
Earnings Per Share, Diluted -2.36 USD/shares +3.28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.7M USD -54.4%
Cash, Cash Equivalents, and Short-term Investments 47.2M USD -56.6%
Accounts Receivable, after Allowance for Credit Loss, Current 5.9M USD +7.56%
Inventory, Net 5.31M USD -17.4%
Assets, Current 61.3M USD -50.8%
Property, Plant and Equipment, Net 6.85M USD +42.6%
Operating Lease, Right-of-Use Asset 787K USD -32.7%
Other Assets, Noncurrent 1.4M USD -25%
Assets 70.3M USD -46.9%
Accounts Payable, Current 2.16M USD -63.4%
Liabilities, Current 17.1M USD -35.3%
Operating Lease, Liability, Noncurrent 565K USD -32.2%
Other Liabilities, Noncurrent 202K USD
Liabilities 17.8M USD -34.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16K USD -40.7%
Retained Earnings (Accumulated Deficit) -333M USD -23.7%
Stockholders' Equity Attributable to Parent 52.5M USD -50.1%
Liabilities and Equity 70.3M USD -46.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.7M USD +7.78%
Net Cash Provided by (Used in) Financing Activities -10K USD -225%
Net Cash Provided by (Used in) Investing Activities 10.6M USD -35.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 24.7M shares +0.52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.11M USD -83.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 58K USD 0%
Deferred Tax Assets, Valuation Allowance 122M USD +69%
Deferred Tax Assets, Gross 72.7K USD
Operating Lease, Liability 833K USD -34.3%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 739K USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -63.7M USD +2.93%
Lessee, Operating Lease, Liability, to be Paid 940K USD -35.3%
Property, Plant and Equipment, Gross 7.31M USD +44.1%
Operating Lease, Liability, Current 268K USD -38.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 231K USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 320K USD -37.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107K USD -42.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 280K USD +21.2%
Deferred Tax Assets, Operating Loss Carryforwards 49.2M USD +12.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.37M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 109K USD -61.1%
Operating Lease, Payments 126K USD +1.61%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Depreciation, Depletion and Amortization 50K USD +31.6%
Deferred Tax Assets, Net of Valuation Allowance 390K USD -30.4%
Interest Expense 231K USD +0.44%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%